Menu

Home / For Visitors / 2025 Exhibitor Product / Kemobotin (Carboplatin)

Kemobotin (Carboplatin)

Model: Liquid Injection (in vial)

Category: Pharmaceutical

Exhibitor: CKD OTTO PHARMACEUTICALS

Booth No: M625

Characteristic

Strength : 150 mg & 450 mg
Dosage form : Liquid Injection
Indication: Advanced ovarian carcinoma, SCLC, squamous cell carcinoma of the head and neck, advanced transitional cell carcinoma of the bladder, significant responses have been observed when KEMOBOTIN® employed in the treatment of carcinoma of the cervix.

KEMOBOTIN® is frequently used in combination with other chemotherapeutic agent in various indications, such as with paclitaxel in first line therapy of ovarian carcinoma and non small cell lung cancer.

Storage Condition :
Store 2-8°C, protect from direct sunlight, do not freeze.

Other Products

Products you may be interested in

Highest Rated Products

TOP